The HVEM Network: New Directions in Targeting Novel Costimulatory/Co-Inhibitory Molecules for Cancer Therapy

Current Opinion in Pharmacology - Netherlands
doi 10.1016/j.coph.2012.03.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Characterization of Novel Costimulatory Molecules

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

mTOR Co-Targeting Strategies for Head and Neck Cancer Therapy

Cancer and Metastasis Reviews
Cancer ResearchOncology
2017English

The Impact of New Targeting Methods in the Cancer Therapy

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2019English

Cancer Stroma-Targeting Therapy: A New Tool for Fighting Pancreatic Cancer?

Annals of Gastroenterological Surgery
2019English

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-Stimulatory Receptor Signaling for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2015English

New Directions in Antiplatelet Therapy

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Targeting Costimulatory Pathways in Systemic Sclerosis

Frontiers in Immunology
AllergyImmunology
2018English

New Directions in Immunoglobulin Therapy

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Targeting Metabolism for Cancer Therapy

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy